He turned around, his eyes devoid of anger, only an extre rational chill: "Who made this decision? Who forced Professor Yang to retract K Therapy?"
"It’s said that in so countries, the theory has been... unfairly treated and overly regulated, with the United States being the worst."
Old Walker was silent for a few seconds, then picked up his phone. "I understand. You can continue your transition plan, but my treatnt will not stop."
He walked out of Griffin’s office and dialed a number.
"Mike, it’s , Walker. I need you to look into a few things, use all connections, yes, about the withdrawal of K Therapy from the United States. I want to know who is pushing this to happen, I want every na, every institution, every related regulatory docunt or congressional proposal. Also, contact all the important friends you know who are receiving or waiting for K Therapy, from Washington to Wall Street and Silicon Valley, we need to talk."
Similar scenes were repeated at the Harvard dical School Affiliated Center in Boston, at the morial Sloan-Kettering Cancer Center in New York, Hopkins... across the list of sixteen countries.
Patients who had the opportunity for K Therapy had already been rigorously screened—they were either extrely financially powerful, had imnse social influence, or their conditions were so complex they had no other choice. They were not the silent majority; they were the few with energy and resources.
Panic and anger first spread silently but intensely in this tiny circle at the top of the pyramid, like a supernova explosion.
An anonymous, encrypted server file appeared in Tang Shun’s inbox. The sender ID was a string of gibberish, with the subject containing only one word: LIST.
Opening the file, it was a ticulously organized table, the contents of which made Tang Shun take a sharp breath.
The table detailed information on so patients in the sixteen countries affected directly by the withdrawal decision of K Therapy in the past seventy-two hours. It’s terd "so" because the list was already alarming enough:
United States:
Raymond Walker: Chairman of the US Senate Appropriations Committee
Marku Reynolds: Founder and CEO of the world’s largest social dia platform
Alex Carter (AI giant founder)
Richard P. Watson (Federal Senator, senior mber of the Energy and Comrce Committee)
Jas "Jim" Colbert (co-founder of a top hedge fund)
Maria Chen (Nobel Prize winner in Physics)
(Following are seven more, including a spouse of a Supre Court Justice, two top Hollywood producers, and three Forbes top 100 family heirs)
United Kingdom:
Lady Lillian Windsor: Key mber of the Windsor family.
Lord Charles W. Ellington (forr Cabinet Minister, now Upper House mber)
Sarah P. Mitchell (BBC Board mber, daughter of a dia mogul)
(Four more)
Germany, Switzerland... the list goes on, with each na representing wealth, power, prestige, or intellectual capital.
More critically, the last column of the table marked the dependency of each patient on K Therapy: "The only effective solution."
The attachnt included several summaries, apparently summarizing the recent activities of these individuals’ agents or families:
"Walker’s office has demanded a full briefing from the FDA and NIH, questioning whether ’unreasonable regulatory discrimination’ is involved."
"Reynolds and Carter have contacted at least twelve Silicon Valley CEOs and venture capitalists to form a temporary communication group."
"Colbert’s hedge fund is analyzing major pharmaceutical giants’ stock prices, seemingly intending to short them."
"Lady Lillian Windsor and Lord Ellington have lodged an urgent inquiry in the Upper House, asking the Health Minister to explain ’why UK patients are losing one of the world’s most advanced cancer treatnts’."
Tang Shun imdiately forwarded this list to Yang Ping.
The eting was swiftly convened.
"The source of this list?" Yang Ping asked.
"Completely anonymous, untraceable, but the details are very real, so even involve undisclosed treatnt details, not fabricable by outsiders," Tang Shun said, "It might be compiled and shared proactively by soone within these patient groups, or... so internal person is dissatisfied with this decision."
"Or soone wants to muddy the waters," Song Zimo added.
Lu Xiaolu stared at the list, his eyes shining: "Professor, regardless of who provided it, this is a sharp knife. No, it’s the launch code for a nuclear bomb. If these people unite, their energy is enough to overturn and crush any pharmaceutical lobbying group."
Yang Ping silently looked at the unfamiliar nas and titles on the screen. When he made the decision to withdraw, he considered the purity of the theory and the long-term developnt of the team, and breaking the unfair siege. He certainly knew this would affect patients, but it was an inevitable choice.
"We don’t need to actively use this list," Yang Ping slowly spoke, "But we need to make everyone know, the consequences of withdrawal are real and concrete, it falls on living people, not concepts, Zhang Lin."
"Yes!"
"There might be more intense public backlash coming up, accusations against us for ’disregarding patient lives’ will reach a peak, you need to adjust your response strategy."
"Please direct, Professor."
"Shift from explaining ’why we withdrew’ to elaborating ’what forced us to withdraw.’ The key is not to complain, but to present a logical chain: certain forces attempting to stifle the theory with non-scientific ans → theory withdraws from its impact range → patients relying on the therapy bear the consequences. Make the chain of responsibility public and clear."
User Comments
0 comments from readers